Cargando…
P1552: AN IMMUNE ATLAS OF THE DYSFUNCTIONAL CELLULAR AND ANTIBODY RESPONSE TO COVID-19 VACCINATION IN HEMATOLOGICAL PATIENTS WITH A MATURE B-CELL NEOPLASM
Autores principales: | Martín-Sánchez, Esperanza, Guerrero, Camila, Tamariz-Amador, Luis-Esteban, Zherniakova, Anastasiia, Zabaleta, Aintzane, Maia, Catarina, Blanco, Laura, Fortuño, Maria-Antonia, Grande, Carlos, Manubens, Andrea, Arguiñano, Jose-Maria, Perez, Clara Gomez, Persona, Ernesto Perez, Eizaguirre, Iñigo Olazabal, Oiartzabal, Itziar, Panizo, Carlos, Prosper, Felipe, Miguel, Jesús San, Rodríguez-Otero, Paula, Paiva, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429908/ http://dx.doi.org/10.1097/01.HS9.0000973084.45364.14 |
Ejemplares similares
-
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
por: Tamariz-Amador, Luis-Esteban, et al.
Publicado: (2021) -
P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Tamariz-Amador, L.-E., et al.
Publicado: (2022) -
Senate Bill No. 1552
Publicado: (1896) -
Defeat Senate Bill 1552
Publicado: (1896) -
Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study
por: García‐Muñoz, Ricardo, et al.
Publicado: (2019)